Popular search terms:
Search Results
28 results found-
CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government’s outbreak and preparedness response.
https://www.cslseqirus.ca/news/csl-seqirus-announces-us-government-award-in-response-to-avian-influenza -
CSL Seqirus welcomes the federal government’s announcement highlighting the creation of a new agency, Health Emergency Readiness Canada (HERC), ensuring that Canada is prepared for future health emergencies.
https://www.cslseqirus.ca/news/health-emergency-readiness-canada -
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.cslseqirus.ca/news -
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.cslseqirus.ca/news/news-archives -
Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
https://www.cslseqirus.ca/news/news-archives/seqirus-ready-to-reinforce-canadas--influenza-pandemic-preparedness-plans -
FLUAD® Influenza vaccine (surface antigen, inactivated, adjuvanted with MF59® is now preferentially recommended by the Comité sur l’immunisation du Québec for adults 65 years of age and older.
https://www.cslseqirus.ca/news/fluad-adjuvanted-flu-vaccines-for-quebec-seniors-csl-seqirus-welcomes-the-ciq-recommendation -
Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons
https://www.cslseqirus.ca/news/recently-published-real-world-evidence-study -
CSL Seqirus Commends the National Advisory Committee on Immunization for Preferential Recommendation of Enhanced Influenza Vaccines for Adults 65 and Older
https://www.cslseqirus.ca/news/seqirus-commends-naci-for-preferential-influenza-for-adults-65-and-older -
Despite high burden of disease, influenza continues to suffer from perceived lack of risk, contributing to low vaccine uptake among parents and Canadian adults
https://www.cslseqirus.ca/news/news-archives/canadian-surveys-highlight-flu-ed-with-healthcare-pros-ease-of-access-critical-vaccination-uptake -
The Government of British Columbia has recently announced that this season they will publicly fund FLUAD®, an inactivated, adjuvanted seasonal influenza vaccine indicated for all seniors residing in a community setting.
https://www.cslseqirus.ca/news/news-archives/csl-seqirus-ca-gov-of-brit-columbias-decision-make-fluad-publicly-avail-all-brit-columbian-seniors